Impact Factor
3.96
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.30
1,060 total citations
h5-index
39
h5 depth signal
Cited share
82.9%
180 of 217
Total citations
1,060
Citation footprint
Metric signal
5.27
External metric anchor
Self-citation
6.4%
68 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
329
Japan
103
United States
89
France
69
South Korea
68
Citing Fields of Research
Digestive Disorders
826
Antibiotic & Antibacterial Agents
166
Bacteriology
158
Inflammatory Bowel Diseases & Infections
73
Immunology
50
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,655
Articles tracked across the journal lifetime
Indexed publication set
217
180 cited publications
Last 12 months
81
13.5 publications/month
Open access share
33.3%
27 OA publications in the last year
Leading citing country
China
329 citing publications
Leading citing field
Digestive Disorders
826 citing publications
Latest tracked publication
8 September 2026
10 recent records available
Coverage & Indexing History
v1n1,Mar. 1996-
v1n1,Mar. 1996-
Active Coverage
Research Focus & Classification
Indexed Subjects
Digestive Disorders
Broad Categories
Bacteriology
Digestive Disorders
MeSH Descriptors
Helicobacter Infections
Helicobacter
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/hel.70162
Open DOI
Population‐Level Trends in Gastric Cancer Mortality and Incidence After Expansion of Japanese National Health Insurance Coverage for Helicobacter pylori Eradication: A Descriptive Time‐Trend Study
Background: In February 2013, Japanese national health insurance coverage for Helicobacter pylori eradication was expanded to patients with H. pylori ‐positive, endoscopically diagnosed chronic gastritis. This policy broadened access to ...
02
DOI 10.1111/hel.70143
Open DOI
Issue Information
03
DOI 10.1111/hel.70164
Open DOI
A Novel Helicobacter pylori Test Based on 16S rRNA Isothermal Amplification Point‐of‐Care Testing of Throat Swab
Background: Helicobacter pylori ( H. pylori ) infection is a major risk factor for gastric cancer (GC) and other gastrointestinal diseases. Current non‐invasive detection methods for H. pylori , such as 13 C‐urea breath test (UBT), are c...
04
DOI 10.1111/hel.70158
Open DOI
Management Strategies for Helicobacter pylori —Application of the Stewardship Principles
The management strategies for Helicobacter pylori treatment are still diverse, especially because of the unequal availability of the drugs needed. In addition, the development of resistance to some antibiotics leads to unsatisfactory res...
05
DOI 10.1111/hel.70171
Open DOI
Efficacy of Standard Triple Therapy With or Without Statin in Helicobacter pylori Eradication: A Randomized Double‐Blind Placebo‐Controlled Trial
Background and Aims: Standard triple therapy (STT) for Helicobacter pylori ( H. pylori ) infection has become suboptimal. Atorvastatin may improve eradication rates by promoting autophagy and reducing inflammation. This study aimed to ev...
06
DOI 10.1111/hel.70168
Open DOI
Intermediate OLGA / OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta‐Analysis
Background: The Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) systems stratify gastric cancer (GC) risk according to the extent of gastric atrophy and intestinal meta...
07
DOI 10.1111/hel.70165
Open DOI
Beyond Helicobacter pylori : Prevalence, Coinfection, and Clinicopathologic Patterns of Non‐ Helicobacter pylori Helicobacter (NHPH) in Human Gastric Biopsies
Background: Non‐
Helicobacter pylori
Helicobacter
(NHPH) species are increasingly recognized as human gastric colonizers, yet their prevalence, species distribution,...
08
DOI 10.1111/hel.70161
Open DOI
Opportunistic Gastric Cancer Endoscopic Screening Integrated Into Population‐Based Colorectal Cancer Screening: A Retrospective Economic Cost‐Comparison Study
Background: Gastric cancer (GC) remains a major cause of cancer‐related mortality worldwide, with prognosis and treatment costs strongly influenced by disease stage at diagnosis. Endoscopic GC screening has been proposed for intermediate...
09
DOI 10.1111/hel.70163
Open DOI
Epidemiology of Helicobacter pylori and Gastric Atrophy in Rural Southwestern Uganda: The ENIGMA Uganda Study
Background: Characterizing the epidemiology of Helicobacter pylori ( H. pylori ) infection and gastric atrophy (GA) is essential for informing preventive strategies in anticipation of the rising gastric cancer burden. The International A...
10
DOI 10.1111/hel.70154
Open DOI
Antimicrobial Resistance Profile of Helicobacter pylori in Shenzhen, China: A Retrospective Study From 2021 to 2024
Background: The escalating antibiotic resistance of Helicobacter pylori ( H. pylori ) poses a significant threat to global public health. Continuous local surveillance is crucial due to substantial geographical and temporal variations in...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 15, no. 6 (2010)
Also issued online.